Cannabis is a mind-altering drug derived from a plant called “Cannabaceae” and is consumed by either smoking or consuming products that have been infused with chemicals found in the plant, namely THC and CBD. While the drug has had a shaky history with the US government, several states have started legalizing the drug in both medical and recreational use cases due to shifting cultural sentiment about cannabis. For medical use cases, a consultation with a professional is required, and, in most instances, the patient is provided with a cannabis card that serves as a prescription at any authorized dispensary.
As of late 2022, around 38 states have legalized medical cannabis and around 19 states have legalized recreational cannabis. Estimates show that nine more states are slated to legalize recreational cannabis by 2030. This has led to an emergence of a cannabis economy, composed of cultivators, extractors and infusers, specialized retailers, prescribers, and consultants.
*Note: Currently, we do not actively cover this industry, but we have identified it as a potential industry to cover.
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. Tilray cultivates and delivers the benefits of medical cannabis safely and reliably. Healthcare practitioners and patients expect and deserve only the best service and products. Accordingly, Tilray provides expedited delivery, prompt follow-up, and consistent quality of each strain they harvest.
Extractors and infusers:
No investor data is available